Radiofrequency antitumor therapy of animals with Walker-256 carcinosarcoma

Article Sidebar

pdf (Українська)
Published: Mar 28, 2011
DOI: https://doi.org/10.20535/2312-1807.2011.16.2.268265

Main Article Content

V.E. Orel
M.O. Nikolov
I.I. Dyatkovskaya
A.V. Romanov
N.M. Dzyatkovska
O.YU. Yaroshenko
A.V. Makarenko

Abstract

The greatest tumor growth inhibition was observed for animals with Walker carcinosarcoma 256 after radiofrequency antitumoral therapy by spatially inhomogeneous electromagnetic field with officinal preparation doxorubicin. According to the scintigraphic studies spatially inhomogeneous electromagnetic field increased blood flow throughout the body and tumor animal, enabling locally visualize nanocomposite Fe3O4 nanoparticles with KCI and radiopharmaceutical in Walker-256 carcinosarcoma.

Article Details

How to Cite
Orel, V. ., Nikolov, M. ., Dyatkovskaya, I. ., Romanov, A. ., Dzyatkovska, N. ., Yaroshenko, O. ., & Makarenko, A. . (2011). Radiofrequency antitumor therapy of animals with Walker-256 carcinosarcoma. Electronics and Communications, 16(2), 110–114. https://doi.org/10.20535/2312-1807.2011.16.2.268265
Issue
Vol. 16 No. 2 (2011)
Section
Biomedical devices and systems
Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Authors who publish with this journal agree to the following terms:

  1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
  2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
  3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).

References

S. Osinsky and P. Vaupel, Microphysiology tumors, Kyiv: Nauk. Dumka, 2009, p. 254.

M. Plotkin, “F-FET PET for planning of thermotherapy using magnetic nanoparticles in recurrent glioblastoma : Hot Topic”, International Journal of Hyperthermia, vol. 22, no. 4, pp. 319–325, Jan. 2006. DOI:10.1080/02656730600734128

V. Orel, Chaos and cancer, mechanochemistry, mechanoemission, Kyiv: AOZT "Teleoptik", 2002, p. 296.

B. Movchan, “Electron-beam nanotechnology and new materials in medicine -first steps”, Visn. pharmacol. and pharmacies., no. 12, pp. 5–13, 2007.

V. Orel, A. Shevchenko, and Y. Melnik, “Physico-chemical characteristics of the magnetically sensitive nanocomplex, from the mechano-magnetochemical technology of dry synthesis”, Metallophysics and the latest technologies, vol. 32, no. 9, pp. 1157–1167, 2010.

N. Emanuel, Kinetics of experimental tumor processes, Moscow: Science, 1977, p. 419.

V. Orel and A. Romanov, “The Effect of Spatially Inhomogeneous Electromagnetic Field and Local Inductive Hyperthermia on Nonlinear Dynamics of the Growth for Transplanted Animal Tumors”, in Nonlinear Dynamics, InTech, 2010. DOI:10.5772/6953

E. Amstad, T. Gillich, I. Bilecka, M. Textor, and E. Reimhult, “Ultrastable Iron Oxide Nanoparticle Colloidal Suspensions Using Dispersants with Catechol-Derived Anchor Groups”, Nano Letters, vol. 9, no. 12, pp. 4042–4048, Oct. 2009. DOI:10.1021/nl902212q

B. Orel, I. Smolanka, and I. Dzyatkovskaya, “Radiofrequency therapy in oncology”, Journal of the Academy of Medical Sciences of Ukraine, vol. 15, no. 2, pp. 289–309, 2009.

V. Kundin, “Diagnostic significance of scintigraphic findings with 99mTc-phosphates”, Ukrainian Radiological Institutemagazine, vol. 12, pp. 255–259, 2004.